BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37080415)

  • 21. Long non-coding RNA tumor protein 53 target gene 1 promotes cervical cancer development via regulating microRNA-33a-5p to target forkhead box K2.
    Liao D; Liu X; Yuan X; Feng P; Ouyang Z; Liu Y; Li C
    Cell Cycle; 2022; 21(6):572-584. PubMed ID: 35090377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circular RNA nuclear receptor interacting protein 1 promoted biliary tract cancer epithelial-mesenchymal transition and stemness by regulating the miR-515-5p/AKT2 axis and PI3K/AKT/mTOR signaling pathway.
    Gao X; Yu S; Liu S; Zhang S; Sha X; Sun D; Jiang X
    Environ Toxicol; 2023 Nov; 38(11):2632-2644. PubMed ID: 37466171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-1306-5p predicts favorable prognosis and inhibits proliferation, migration, and invasion of colorectal cancer cells via PI3K/AKT/mTOR pathway.
    Wang W; Zhang J; Fan Y; Zhang L
    Cell Cycle; 2022 Jul; 21(14):1491-1501. PubMed ID: 35416128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-218-5p inhibit the migration and proliferation of pterygium epithelial cells by targeting EGFR via PI3K/Akt/mTOR signaling pathway.
    Han S; Chen Y; Gao Y; Sun B; Kong Y
    Exp Eye Res; 2019 Jan; 178():37-45. PubMed ID: 30243568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
    Ye K; Li L; Wu B; Wang D
    Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.
    Xu H; Ding Y; Yang X
    Biomed Res Int; 2021; 2021():6619730. PubMed ID: 34250088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The depletion of Circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway.
    Ling Z; Fang ZG; Wu JY; Liu JJ
    Kaohsiung J Med Sci; 2021 May; 37(5):392-401. PubMed ID: 33615686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N(6)-methyladenosine-mediated miR-380-3p maturation and upregulation promotes cancer aggressiveness in pancreatic cancer.
    Jiang Z; Song X; Wei Y; Li Y; Kong D; Sun J
    Bioengineered; 2022 Jun; 13(6):14460-14471. PubMed ID: 35758158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-135 inhibits initiation of epithelial-mesenchymal transition in breast cancer by targeting ZNF217 and promoting m6A modification of NANOG.
    Xu LM; Zhang J; Ma Y; Yuan YJ; Yu H; Wang J; Cao XC; Zhu L; Wang P
    Oncogene; 2022 Mar; 41(12):1742-1751. PubMed ID: 35121826
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway.
    Zhang YM; Wu QM; Chang LY; Liu JC
    Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demethylase FTO inhibits the occurrence and development of triple-negative breast cancer by blocking m
    Ni J; Lu X; Gao X; Jin C; Mao J
    Acta Biochim Biophys Sin (Shanghai); 2024 Jan; 56(1):114-128. PubMed ID: 38151999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
    Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
    J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway.
    Xiao R; Wang H; Yang B
    Bioengineered; 2021 Dec; 12(2):10596-10607. PubMed ID: 34895048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. microRNA-16-5p suppresses cell proliferation and angiogenesis in colorectal cancer by negatively regulating forkhead box K1 to block the PI3K/Akt/mTOR pathway.
    Huang X; Xu X; Ke H; Pan X; Ai J; Xie R; Lan G; Hu Y; Wu Y
    Eur J Histochem; 2022 May; 66(2):. PubMed ID: 35536149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FTO-mediated m6A demethylation of pri-miR-3591 alleviates osteoarthritis progression.
    Liu W; Jiang T; Zheng W; Zhang J; Li A; Lu C; Lin Z
    Arthritis Res Ther; 2023 Apr; 25(1):53. PubMed ID: 37005694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hsa_circ_CSPP1/MiR-361-5p/ITGB1 Regulates Proliferation and Migration of Cervical Cancer (CC) by Modulating the PI3K-Akt Signaling Pathway.
    Yang W; Xie T
    Reprod Sci; 2020 Jan; 27(1):132-144. PubMed ID: 32046405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of miR-99b-5p and Upregulation of Nuclear mTOR Cooperatively Promotes the Tumor Aggressiveness and Drug Resistance in African American Prostate Cancer.
    Gujrati H; Ha S; Waseem M; Wang BD
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway.
    Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R
    Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA RHPN1-AS1 Promotes Cell Proliferation, Migration and Invasion Through Targeting miR-7-5p and Activating PI3K/AKT/mTOR Pathway in Hepatocellular Carcinoma.
    Song XZ; Ren XN; Xu XJ; Ruan XX; Wang YL; Yao TT
    Technol Cancer Res Treat; 2020; 19():1533033820957023. PubMed ID: 32910747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.